SCHEMBL13492001

SCHEMBL13492001

CC1CC(C)(C(F)(F)F)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19432438 0.76 — —
SCHEMBL24123678 0.72 — —
SCHEMBL21917970 0.72 — —
SCHEMBL24123677 0.72 — —
SCHEMBL24123809 0.72 — —
SCHEMBL13856050 0.70 — —
SCHEMBL24768892 0.69 — —
SCHEMBL21919197 0.69 — —
SCHEMBL21815210 0.69 — —
SCHEMBL13856021 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041717-A1 N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPAN-1-AMINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2010-02-18 — — US disclosed
Send feedback